|
EspAddText
EspRemoveText
|
Rural and remote practice issues
|
Policy document
|
2020
|
|
EspAddText
EspRemoveText
|
Auditing Physician Billings
|
Policy document
|
2019
|
|
EspAddText
EspRemoveText
|
Mental Health, Mental Illness & Addiction : CMA Submission to the Standing Committee on Social affairs, Science and Technology
|
Parliamentary submission
|
2012
|
|
EspAddText
EspRemoveText
|
Cannabis for Medical Purposes
|
Policy document
|
2019
|
|
EspAddText
EspRemoveText
|
Medication use and seniors (Update 2017)
|
Policy document
|
2019
|
|
EspAddText
EspRemoveText
|
CMA's Submission to Finance Canada regarding proposed amendments to the Income Tax Act
|
Parliamentary submission
|
2012
|
|
EspAddText
EspRemoveText
|
CMA's Submission to the House of Commons Standing Committee on Finance: Amending Bill C-25 to expand the PRPP framework to provide value to self-employed Canadians
|
Parliamentary submission
|
2012
|
|
EspAddText
EspRemoveText
|
CMA's Submission to the House of Commons Standing Committee on Health: Drug Shortages
|
Parliamentary submission
|
2012
|
|
EspAddText
EspRemoveText
|
CMA Presentation to the Senate Standing Committee on Social Affairs, Science and Technology - Prescription Drugs: Clinical Trials and Approval
|
Parliamentary submission
|
2012
|
|
EspAddText
EspRemoveText
|
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology - Prescription Pharmaceuticals in Canada: The Post-Approval Monitoring of Prescription Pharmaceuticals
|
Parliamentary submission
|
2012
|
|
EspAddText
EspRemoveText
|
Vision for e-Prescribing: a joint statement by the Canadian Medical Association and the Canadian Pharmacists Association
|
Policy document
|
2019
|
|
EspAddText
EspRemoveText
|
CMA Response: Health Canada's Medical Marijuana Regulatory Proposal
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
Canadian Medical Association Submission on Motion 315 (Income Inequality)
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
The treating physician's role in helping patients return to work after an illness or injury (Update 2013)
|
Policy document
|
2020
|
|
EspAddText
EspRemoveText
|
Position statement on prescription drug shortages in Canada
|
Policy document
|
2017
|
|
EspAddText
EspRemoveText
|
Canadian Medical Association Submission on Bill C-462 Disability Tax Credit Promoters Restrictions Act
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
The Need for a National Strategy to Address Abuse and Misuse of Prescription Drugs in Canada: Canadian Medical Association Submission to the House of Commons Standing Committee on Health
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
Physician compensation (Update 2013)
|
Policy document
|
2018
|
|
EspAddText
EspRemoveText
|
Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations
|
Response to consultation
|
2014
|
|
EspAddText
EspRemoveText
|
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety
|
Parliamentary submission
|
2014
|